Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Immunotherapy in Oral Squamous Cell Carcinoma

Immunotherapy in Oral Squamous Cell Carcinoma

Singh, Akanchha
Gupta, Shalini
Tomar, Arushi

Paperback

Medical Reference

ISBN10: 6208438500
ISBN13: 9786208438500
Publisher: LAP Lambert Academic Publishing
Published: May 6 2025
Pages: 108
Weight: 0.34
Height: 0.26 Width: 6.00 Depth: 9.00
Language: English
Immunotherapy has emerged as a promising modality in the treatment of Oral Squamous Cell Carcinoma (OSCC), particularly for advanced and recurrent cases. Unlike conventional therapies, which target the tumor directly, immunotherapy harnesses the body's immune system to recognize and destroy cancer cells. The most widely studied approach in OSCC involves immune checkpoint inhibitors targeting the PD-1/PD-L1 axis. Drugs like nivolumab and pembrolizumab have demonstrated improved survival rates in patients with recurrent or metastatic OSCC, especially those with PD-L1 expression.Combining immunotherapy with surgery, radiotherapy, or chemotherapy is being explored to increase efficacy. As research progresses, personalized immunotherapy guided by molecular profiling holds the potential to significantly improve prognosis and quality of life for OSCC patients. Continuous clinical trials and translational research are critical to overcoming current limitations and expanding its therapeutic role.

1 different editions

Also available

Also from

Singh, Akanchha

View All

Also in

Medical Reference

View All